| Project/Area Number |
24591886
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | Nara Medical University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
ISHITANI Akiko 奈良県立医科大学, 医学部, 非常勤講師 (40112544)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
ICHINOHE Tatsuo 広島大学, 医学部, 教授 (80314219)
TAKAHARA Shiro 大阪大学, 医学(系)研究科(研究院), 寄付講座教授 (70179547)
UEMOTO Shinji 京都大学, 医学(系)研究科(研究院), 教授 (40252449)
YOSHIDA Katsunori 奈良県立医科大学, 医学部, 教授 (50192422)
MORII Takeshi 奈良県立医科大学, 医学部, 講師 (70268451)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Keywords | 移植外科学 / HLA-F / 制御性T細胞 / 移植 / 拒絶反応 / 非古典的ＨＬＡクラスＩ / ＨＬＡ－Ｆ |
|---|
| Outline of Final Research Achievements |
HLA-F is expressed on the cell surface of activated immune cells except for regulatory T cells. We considered that HLA-F expressing immune cells except for regulatory T cells associated with rejection. To aim the establishment of new immunosuppression system by elimination of HLA-F positive cells, we analyzed the expression of HLA-F on peripheral lymphocyte from patients who received transplantation.
We analyzed 1538 samples from 265 patients who received transplantation including 99 liver transplantation, 114 kidney transplantation and 52 stem cell transplantation. We detected HLA-F positive cells on peripheral lymphocyte from patients who received transplantation, although the HLA-F expression did not associate with rejection. Additionally, we detected HLA-F expression on steady-state B cells. We concluded that it was difficult to establish the new immunosuppression system using by HLA-F expression.
|
